Chromatindynamics and metabolism in cancer - Lab members

  • Svetlana Dokudovskaya, DR2 CNRS
  • Yegor Vassetzky, DR1 CNRS
  • Joëlle Wiels, DREM CNRS
  • Marc Lipinski, DREM CNRS
  • Yahir Alberto Loissel Baltazar, PhD student (Université Paris-Saclay)
  • Anna Shmakova, PhD student (Université Paris-Saclay)
  • Zhenrui Pan, PhD student (Université Paris-Saclay-CSC)
  • Anna Karpukhina, PhD student (Université Paris-Saclay)
  • Junyi Feng,  PhD student (Université Paris-Saclay-CSC)
  • Haoran Chai, PhD student (Université Paris-Saclay-CSC)

 

Chromatindynamics and metabolism in cancer - Publications

Major publications

  • Shmakova, A, Lomov, N., Viushkov, V., Tsfasman, T.,  Kozhevnikova, Y., Sokolova, D., Pokrovsky, V., Syrkina, M., Germini, D., Rubtsov, M.,  and VASSETZKY, Y.S. (2022) Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations. Cancer Communications, DOI: 10.1002/cac2.12370

Chromatindynamics and metabolism in cancer

Chromatindynamics and metabolism in cancer

This group belongs to the UMR 9018 - Metabolic and systemic aspects of oncogenesis for novel therapeutic approaches (Metsy)

We are working on the founding events in oncogenesis. Our approach allows us to search for early biomarkers of cancers and develop cancer-preventive approaches.

Adolescents and Young Adults - Team

The AYA team

A non-hierarchical, multidisciplinary, innovative team which carries through projects and has links outside Gustave Roussy.

The team consists of:

Adolescents and Young Adults - Therapeutic education

Programme of education about therapy for AYA

AGORA* is designed to help patients adapt to their illness and its treatment, so encouraging independence in their approach to improving their quality of life.    

Adolescents and Young Adults - Presentation

The treatment of adolescents and young adults

Cancer is a rare condition in those aged between 13 and 25 years. It is, therefore, important to recognise the special situation of patients in this age group being treated for malignant disease (educational, work-related, physiological, psychological and social) and to tailor treatment accordingly.   

In 2002, the Department of Childhood and Adolescent Oncology established the first unit for adolescents (13-20 years) with cancer, known as « La Montagne » (The Mountain).

Pages